GlassScriptPhysician profile
Mukesh Goel
NPI 1770618837
$6,170.74
in general payments reported to CMS, 2019-2025
24 companies · $5,513 in 2025
The $5,513 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.66 · 2021: $143 · 2022: $132 · 2023: $106 · 2024: $177 · 2025: $5,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,333 · Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,333.33 |
| Food and Beverage | $463.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $5,480.45 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.92 | 2022-2024 | Jardiance |
| Philips North America LLC | $59.10 | 2022-2025 | Ecc Solutions, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $57.10 | 2021-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.21 | 2022-2025 | Lifevest |
| Amarin Pharma, INC. | $44.37 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $41.81 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $32.21 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $31.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $31.03 | 2023-2024 | Farxiga |
| Amgen INC. | $30.26 | 2023-2025 | Repatha |
| Celgene Corporation | $28.55 | 2025 | Eliquis |
| Organogenesis INC. | $26.04 | 2024 | Affinity |
| Braemar Manufacturing, LLC | $23.52 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $21.13 | 2024 | Arcalyst |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $21.08 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.97 | 2023 | Onpattro |
| Pfizer INC. | $15.71 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.52 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $14.42 | 2019 | |
| Bard Peripheral Vascular, INC. | $14.29 | 2021 | |
| Terumo Medical Corporation | $13.34 | 2022 | |
| Cordis US Corp. | $12.96 | 2022 | |
| Acist Medical Systems, INC. | $5.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mukesh Goel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.